DDX5 Alleviates Temporomandibular Joint Osteoarthritis via TNF ‐Induced NF ‐ κB Signaling Pathway
Oral Diseases · 2025
DOI: 10.1111/odi.15294 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2025. Verfasst von Qingqing Liang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Research Institute of Stomatology, Nanjing University, Nanjing, China. Hauptthemen laut MEDLINE: Osteoarthritis, NF-kappa B, Tumor Necrosis Factor-alpha, DEAD-box RNA Helicases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Mountain Climbing Talents Project of Nanjing University, National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Background
Temporomandibular joint osteoarthritis (TMJOA) is a prevalent musculoskeletal condition characterized by pain, cartilage degeneration, and subchondral bone loss.
Objective
This study sought to identify specific targets for the treatment of TMJOA.
Method
Through high‐throughput RNA‐seq analysis in condylar chondrocytes (NC vs. MS), we discovered that DDX5 was downregulated and closely negatively related to the progression of TMJOA. Similarly, we found that DDX5 was downregulated in injured condylar cartilage of patients as well as the condyles of UAC‐induced TMJOA mice. The chondrocyte‐specific deletion of Ddx5 aggravated tissue destruction in TMJOA modeling by inducing degradation of extracellular matrix (ECM).
Results
The loss of DDX5 facilitated chondrocyte degradation and the occurrence of joint inflammation in condylar chondrocytes. In addition, the local injection of AAV overexpressing DDX5 significantly alleviated inflammation, cartilage degradation, and subchondral bone loss in TMJOA mice. RNA‐seq analysis revealed that the DDX5 deficiency mostly activated the TNF‐induced nuclear factor‐kappa B (NF‐κB) signaling pathway causing the occurrence of TMJOA.
Conclusion
Mechanistically, the inhibition of DDX5 accelerated cartilage degeneration by activating TNF‐induced NF‐κB signaling. Thus, DDX5 emerges as a potential effective drug target for future therapeutic approaches in TMJOA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Research Institute of Stomatology, Nanjing University, Nanjing, China.
- State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China.
- Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, China.
- Affiliated Shanghai Ninth People's Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.
Förderung
- Mountain Climbing Talents Project of Nanjing University
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- "Science and Education Strengthening Health Project" young medical talents
- School of Life Science (NJU)-Sipimo Joint Funds
- Key Project supported by Medical Science & Technology Development Foundation of Nanjing Department of Health
- Nanjing University
Zitieren
APA
Liang, Q., Han, P., Han, M., Wang, M., Zhao, Q., Zhang, Y., Ye, C., Chen, S., Fang, B., Sun, Y., & Ji, J. (2025). DDX5 Alleviates Temporomandibular Joint Osteoarthritis via TNF ‐Induced NF ‐ κB Signaling Pathway. Oral Diseases. https://doi.org/10.1111/odi.15294
Vancouver
Liang Q, Han P, Han M, Wang M, Zhao Q, Zhang Y, et al. DDX5 Alleviates Temporomandibular Joint Osteoarthritis via TNF ‐Induced NF ‐ κB Signaling Pathway. Oral Diseases. 2025. doi:10.1111/odi.15294
BibTeX
@article{Liang2025,
author = {Liang, Qingqing and Han, Peiru and Han, Mingrui and Wang, Mengjia and Zhao, Qing and Zhang, Yuan and Ye, Chuanjin and Chen, Sheng and Fang, Bing and Sun, Yang and Ji, Jun},
title = {DDX5 Alleviates Temporomandibular Joint Osteoarthritis via TNF ‐Induced NF ‐ κB Signaling Pathway},
journal = {Oral Diseases},
year = {2025},
doi = {10.1111/odi.15294}
}
EUVIMED